4.5 Article

Functional ryanodine receptors are expressed by human microglia and THP-1 cells: Their possible involvement in modulation of neurotoxicity

期刊

JOURNAL OF NEUROSCIENCE RESEARCH
卷 85, 期 10, 页码 2207-2215

出版社

WILEY
DOI: 10.1002/jnr.21361

关键词

calcium; glia; neurodegeneration; neuro-inflammation; alpha-synuclein

向作者/读者索取更多资源

Ryanodine receptors (RyRs) are intracellular Ca2+ channels that mediate the release of calcium from internal stores and therefore play an important role in Ca2+ signaling and homeostasis. Three RyR isoforms have been described thus far, and various areas of brain are known to express each of them. It is well established that neurons can express different RyR isoforms, but it is not known whether microglial cells do so. In the present study we showed that cultured human microglia from both fetal and adult brain specimens express mRNA for RyR1 and RyR2, whereas RyR3 mRNA can be detected only in fetal microglial cells. Calcium spectrofluorometry showed that high levels of the RyR agonist 4-chloro-m-cresol (4-CmC, 1-5 mM) induced elevation of intracellular Ca2+ concentration ([Ca2+](i)) in both types of cultured human microglial cells. This effect was attenuated by the RyR antagonist 1,1 '-diheptyl-4,4 '-bipyridinium dibromide (DHBP, 10 mu M). Neurotoxicity of conditioned medium from human microglia and THP-1 monocytic cells Stimulated with a combination of interferon-gamma (IFN-gamma) with either lipopolysaccharide (LPS) or alpha-synuclein was diminished by DHBP It was also diminished by,4-CmC at concentrations approximately 100-fold lower than those used to stimulate intracellular Ca2+ release. These data indicate that human microglial cells express functional RyRs and that selective RyR ligands exert antineurotoxic action on this cell type. Therefore, RyR ligands may represent a novel class of compounds that have utility in reducing microglial-mediated inflammation, which is believed to contribute to the pathogenesis of a number of neurodegenerative disorders including Alzheimer's disease and Parkinson's disease. (c) 2007Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据